Symbol Name ID |
Pld1
phospholipase D1 MGI:109585 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Pld1tm1.1Mafr/Pld1tm1.1Mafr Pld2tm1Yaka/Pld2tm1Yaka involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj |
no abnormal phenotype detected | J:192844 |
Pld1tm3Mafr/Pld1tm3Mafr Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg involves: C57BL/6 * C57BL/6NTac |
abnormal enzyme/coenzyme activity | J:216114 |
abnormal platelet activation | J:216114 | |
decreased cerebral infarct size | J:216114 | |
decreased susceptibility to induced thrombosis | J:216114 | |
decreased susceptibility to ischemic brain injury | J:216114 | |
normal homeostasis/metabolism phenotype | J:216114 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/21/2024 MGI 6.24 |
![]() |
|